SAIC Stock Cash Flow Statements

Science Applications International Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Science Applications International Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-08-01	2025-05-02	2025-01-31	2024-11-01	2024-08-02	2024-05-03	2024-02-02	2023-11-03	2023-08-04	2023-05-05	2023-02-03	2022-10-28	2022-07-29	2022-04-29	2022-01-28	2021-10-29	2021-07-30	2021-04-30	2021-01-29	2020-10-30	2020-07-31	2020-05-01	2020-01-31	2019-11-01	2019-08-02	2019-05-03	2019-02-01	2018-11-02	2018-08-03	2018-05-05	2018-05-04	2018-02-02	2017-11-03	2016-05-06	2016-01-29	2015-10-30	2015-07-31	2015-05-01	2015-01-30	2014-10-31	2014-08-01	2014-05-02

cash flows from operating activities:
net income	127,000,000	68,000,000	98,000,000	106,000,000	81,000,000	77,000,000	39,000,000	93,000,000	247,000,000	98,000,000	75,000,000	80,000,000	74,000,000	74,000,000	44,000,000	71,000,000	82,000,000	82,000,000	61,000,000	60,000,000	53,000,000	37,000,000	60,000,000	56,000,000	57,000,000	56,000,000	-9,000,000	61,000,000	49,000,000	49,000,000	49,000,000	67,000,000	58,000,000	33,000,000	28,000,000	34,000,000	22,000,000	33,000,000	36,000,000	37,000,000	34,000,000	34,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	35,000,000	36,000,000	36,000,000	35,000,000	34,000,000	35,000,000	36,000,000	34,000,000	36,000,000	36,000,000	39,000,000	37,000,000	40,000,000	41,000,000	42,000,000	44,000,000	37,000,000	42,000,000	48,000,000	48,000,000	50,000,000	33,000,000	35,000,000	33,000,000	34,000,000	36,000,000	16,000,000	11,000,000	12,000,000	10,000,000	11,000,000	5,000,000	5,000,000	16,000,000	20,000,000	18,000,000	19,000,000	5,000,000	5,000,000	6,000,000	5,000,000	5,000,000
stock-based compensation expense	10,000,000	15,000,000	15,000,000	13,000,000	12,000,000	13,000,000	26,000,000	15,000,000	15,000,000	12,000,000	13,000,000	12,000,000	12,000,000	11,000,000	11,000,000	11,000,000	14,000,000	10,000,000	12,000,000	11,000,000	10,000,000	9,000,000	8,000,000	9,000,000	12,000,000	8,000,000	21,000,000	9,000,000	8,000,000	8,000,000	8,000,000	2,000,000	3,000,000	10,000,000	8,000,000	8,000,000	8,000,000	9,000,000	9,000,000	8,000,000	9,000,000	9,000,000
deferred income taxes			12,000,000	-7,000,000			16,000,000	-8,000,000	-19,000,000	-6,000,000	12,000,000	-7,000,000	-24,000,000	2,000,000	18,000,000	10,000,000	11,000,000	20,000,000	-5,000,000	6,000,000	1,000,000	10,000,000	17,000,000	11,000,000	7,000,000	9,000,000															0	1,000,000
other			-3,000,000	-1,000,000	-2,000,000	-1,000,000	2,000,000	-7,000,000	0	-3,000,000	-5,000,000	0			-1,000,000	-3,000,000	-1,000,000	-1,000,000	-1,000,000	0							0
increase resulting from changes in operating assets and liabilities:
receivables	58,000,000	-9,000,000	22,000,000	-76,000,000	-12,000,000	-20,000,000	96,000,000	-52,000,000	37,000,000	-127,000,000	123,000,000	-23,000,000	68,000,000	-89,000,000	92,000,000	-43,000,000	-19,000,000	-61,000,000	90,000,000	-20,000,000	8,000,000	143,000,000			6,000,000	11,000,000				-43,000,000	8,000,000			-61,000,000	39,000,000	-8,000,000	-19,000,000	-17,000,000	85,000,000	10,000,000	-35,000,000	17,000,000
prepaid expenses and other current assets	-113,000,000	6,000,000	-7,000,000	17,000,000	-1,000,000	15,000,000
accounts payable and other accrued liabilities
accrued payroll and employee benefits	48,000,000	-51,000,000	28,000,000	-27,000,000	51,000,000	-83,000,000	53,000,000	-13,000,000	52,000,000	-43,000,000	-68,000,000	59,000,000	-58,000,000	31,000,000	-35,000,000	25,000,000	-37,000,000	57,000,000	-46,000,000	61,000,000	-3,000,000	83,000,000	-75,000,000	60,000,000	0	18,000,000	-47,000,000	71,000,000	-9,000,000	22,000,000	34,000,000		49,000,000	17,000,000	11,000,000	-16,000,000	30,000,000	-29,000,000	7,000,000	-8,000,000	30,000,000	-25,000,000
operating lease assets and liabilities	-2,000,000	-2,000,000	1,000,000	-2,000,000	-2,000,000	-3,000,000	-1,000,000	-1,000,000	1,000,000	-3,000,000	-2,000,000			-4,000,000	1,000,000	1,000,000	-2,000,000	5,000,000	2,000,000	-2,000,000
other assets and other long-term liabilities	-33,000,000	4,000,000
net cash from operating activities	122,000,000	100,000,000	115,000,000	143,000,000	138,000,000	98,000,000	63,000,000	101,000,000	150,000,000	82,000,000	145,000,000	128,000,000	141,000,000	118,000,000	103,000,000	134,000,000	92,000,000	189,000,000	53,000,000	231,000,000	104,000,000	367,000,000	69,000,000	116,000,000	95,000,000	178,000,000	22,000,000	109,000,000	-12,000,000	88,000,000	88,000,000
capex	-7,000,000	-8,000,000	-15,000,000	-9,000,000	-6,000,000	-6,000,000	-11,000,000	-4,000,000	-6,000,000	-6,000,000	-7,000,000	-6,000,000	-7,000,000	-5,000,000	-9,000,000	-10,000,000	-7,000,000	-10,000,000	-14,000,000	-9,000,000	0	0	0	0	0	0	0	0	0	-4,000,000	0
free cash flows	115,000,000	92,000,000	100,000,000	134,000,000	132,000,000	92,000,000	52,000,000	97,000,000	144,000,000	76,000,000	138,000,000	122,000,000	134,000,000	113,000,000	94,000,000	124,000,000	85,000,000	179,000,000	39,000,000	222,000,000	104,000,000	367,000,000	69,000,000	116,000,000	95,000,000	178,000,000	22,000,000	109,000,000	-12,000,000	84,000,000	88,000,000
cash flows from investing activities:
expenditures for property, plant, and equipment	-7,000,000	-8,000,000	-15,000,000	-9,000,000	-6,000,000	-6,000,000	-11,000,000	-4,000,000	-6,000,000	-6,000,000	-7,000,000	-6,000,000	-7,000,000	-5,000,000	-9,000,000	-10,000,000	-7,000,000	-10,000,000	-14,000,000	-9,000,000										-4,000,000				-4,000,000
purchases of marketable securities	0	-4,000,000	-3,000,000	-3,000,000	-4,000,000	-4,000,000	-2,000,000	-1,000,000	-2,000,000	-3,000,000	-2,000,000	-1,000,000	-2,000,000	-2,000,000	-4,000,000	-2,000,000	-1,000,000	-2,000,000	-1,000,000	-1,000,000
sales of marketable securities	1,000,000	3,000,000	2,000,000	4,000,000	2,000,000	4,000,000	1,000,000	1,000,000	3,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	2,000,000	2,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	6,000,000	1,000,000	0
contributions to investments	-1,000,000	-6,000,000
net cash from investing activities	-7,000,000	-15,000,000	-20,000,000	1,000,000	-9,000,000	-7,000,000	-10,000,000	-10,000,000	-2,000,000	336,000,000	-13,000,000	-6,000,000	-11,000,000	-6,000,000	-20,000,000	-16,000,000	-252,000,000	-4,000,000	-2,000,000	-6,000,000										-4,000,000
cash flows from financing activities:
proceeds from borrowings	557,000,000	750,000,000	385,000,000	441,000,000	380,000,000	293,000,000	0	0	0	160,000,000	210,000,000	115,000,000			0	0	100,000,000	16,000,000	0	0	0	1,000,000,000	0	0			1,068,000,000	766,000,000				-184,000,000			0	0
principal payments on borrowings	-546,000,000	-689,000,000	-325,000,000	-450,000,000	-296,000,000	-310,000,000	-166,000,000	-15,000,000	-100,000,000	-160,000,000	-210,000,000	-205,000,000	-516,000,000	-59,000,000	-35,000,000	-23,000,000	-22,000,000	-39,000,000	-23,000,000	-218,000,000										-9,000,000				-15,000,000	-43,000,000	-13,000,000	-9,000,000	-7,000,000	-6,000,000
stock repurchased and retired or withheld for taxes on equity awards	-110,000,000	-142,000,000	-133,000,000	-121,000,000	-201,000,000	-103,000,000	-89,000,000	-103,000,000	-102,000,000	-88,000,000	-59,000,000	-60,000,000	-64,000,000	-84,000,000	-72,000,000	-63,000,000	-38,000,000	-53,000,000	-21,000,000	-1,000,000										-65,000,000				-47,000,000	-33,000,000	-18,000,000	-1,000,000	-17,000,000	-26,000,000	-51,000,000
dividend payments to stockholders	-17,000,000	-19,000,000	-18,000,000	-18,000,000	-19,000,000	-20,000,000	-19,000,000	-19,000,000	-20,000,000	-21,000,000	-20,000,000	-21,000,000	-20,000,000	-22,000,000	-21,000,000	-21,000,000	-22,000,000	-22,000,000	-22,000,000	-21,000,000										-14,000,000				-14,000,000	-14,000,000	-13,000,000	-15,000,000	-13,000,000	-12,000,000	-13,000,000	-14,000,000	-13,000,000
issuances of stock	6,000,000	6,000,000	6,000,000	5,000,000	5,000,000	4,000,000	4,000,000	5,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	4,000,000	3,000,000	3,000,000	3,000,000	3,000,000	2,000,000	3,000,000	2,000,000	2,000,000	2,000,000	1,000,000	2,000,000	2,000,000	3,000,000	2,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	0	1,000,000
net cash from financing activities	-114,000,000	-94,000,000	-85,000,000	-146,000,000	-131,000,000	-136,000,000	-270,000,000	-132,000,000	-218,000,000	-105,000,000	-76,000,000	-168,000,000	-87,000,000	-162,000,000	-125,000,000	-103,000,000	22,000,000	-95,000,000	-62,000,000	-239,000,000	-162,000,000	927,000,000								-88,000,000
net decrease in cash, cash equivalents and restricted cash	1,000,000	-9,000,000										-46,000,000			-42,000,000															-4,000,000
cash, cash equivalents and restricted cash at beginning of period	0	64,000,000	0	0	0	103,000,000	0	0	0	118,000,000	0	0	0	115,000,000	0	0	0	190,000,000	0	0	0	202,000,000	0	0	0	246,000,000	0	-66,000,000	-66,000,000	218,000,000	152,000,000
cash, cash equivalents and restricted cash at end of period	1,000,000	55,000,000	10,000,000	-2,000,000	-2,000,000	58,000,000	-217,000,000	-41,000,000	-70,000,000	431,000,000	56,000,000	-46,000,000	43,000,000	65,000,000	-42,000,000	15,000,000	-138,000,000	280,000,000	-11,000,000	-14,000,000	-79,000,000	294,000,000	26,000,000	-12,000,000	28,000,000	160,000,000	44,000,000	54,000,000	-100,000,000	214,000,000	160,000,000
science applications international corporation
notes to condensed consolidated financial statements
accounts payable and accrued liabilities		33,000,000	-73,000,000	80,000,000	-19,000,000	60,000,000	-107,000,000	68,000,000	-61,000,000	113,000,000	12,000,000	-50,000,000	-10,000,000	39,000,000	-17,000,000	5,000,000	-2,000,000	44,000,000	-85,000,000	13,000,000	-70,000,000	66,000,000	-16,000,000	57,000,000	1,000,000	20,000,000				16,000,000		62,000,000	67,000,000	10,000,000	8,000,000	38,000,000	-13,000,000	11,000,000	-26,000,000	18,000,000	13,000,000	-24,000,000
gain on divestitures							0	0										-3,000,000
increase resulting from changes in operating assets and liabilities, net of the effect of the acquisitions and divestitures:
other assets			-9,000,000	11,000,000			-19,000,000	8,000,000	-7,000,000	4,000,000	1,000,000	0	2,000,000	3,000,000	5,000,000	0	-4,000,000	-4,000,000	-3,000,000	-4,000,000				16,000,000	16,000,000	11,000,000				1,000,000		3,000,000	2,000,000			0	0	1,000,000				1,000,000
other long-term liabilities			-12,000,000	-1,000,000	7,000,000	5,000,000	3,000,000	6,000,000	13,000,000	2,000,000	13,000,000			-1,000,000	-50,000,000	3,000,000	4,000,000	-3,000,000	-20,000,000	31,000,000	48,000,000	5,000,000					-7,000,000	5,000,000	1,000,000	2,000,000	1,000,000	2,000,000			-2,000,000	-3,000,000	-1,000,000	2,000,000	-1,000,000	1,000,000
proceeds from sale of equity method investments			0
proceeds from divestitures							0	1,000,000							0	0	0	8,000,000
cash divested upon deconsolidation of joint venture							0	0	0	-8,000,000
debt issuance costs											0	-1,000,000							0	0
net increase in cash, cash equivalents and restricted cash			10,000,000	-2,000,000	-2,000,000	-45,000,000	-217,000,000	-41,000,000	-70,000,000	313,000,000				-50,000,000			-138,000,000	90,000,000			-79,000,000	92,000,000					44,000,000				8,000,000
see accompanying notes to consolidated financial statements.
supplementary cash flow disclosure:
cash paid for interest
cash paid for income taxes
non-cash investing activities:
increase in accrued property, plant, and equipment
non-cash financing activities:
increase in accrued plan share repurchases
increase in accrued excise taxes on plan share repurchases
science applications international corporationnotes to the consolidated financial statements
gain on sale of equity method investments and long-lived assets
increase resulting from changes in operating assets and liabilities, net of the effect of divestitures:
income taxes payable				0				-53,000,000				23,000,000																						16,000,000				14,000,000
proceeds from sale of long-lived assets								0
excise tax payments on stock repurchases
(gain) loss on sale of long-lived assets
(gain) loss on divestitures															0	0
proceeds from assets held for sale										355,000,000
amortization of off-market customer contracts							0	-1,000,000	-2,000,000	-2,000,000	-2,000,000	-6,000,000	-4,000,000	-2,000,000	-3,000,000	-13,000,000	-13,000,000	-4,000,000	-4,000,000	-4,000,000
amortization of debt issuance costs							3,000,000	0	3,000,000	1,000,000	1,000,000	2,000,000	4,000,000	2,000,000	1,000,000	2,000,000	2,000,000	2,000,000	2,000,000	7,000,000	6,000,000	6,000,000
impairment of assets
inventory, prepaid expenses, and other current assets
cash paid for acquisitions, net of cash acquired															-8,000,000	-3,000,000
distributions to non-controlling interest											-1,000,000	0	-1,000,000	-1,000,000	-1,000,000	0
non-cash investing and financing activities:
decrease in accrued property, plant, and equipment
gain on sale of long-lived assets								0
inventory, prepaid expenses and other current assets								5,000,000	4,000,000	4,000,000		0	-4,000,000	11,000,000		18,000,000	15,000,000	-5,000,000		24,000,000					-5,000,000	16,000,000			-17,000,000	23,000,000	7,000,000	32,000,000	36,000,000	-2,000,000	-6,000,000	-2,000,000	-6,000,000	3,000,000	-16,000,000	5,000,000	10,000,000	17,000,000
notes to condensed and consolidated financial statements
gain on divestiture										-7,000,000
increase resulting from changes in operating assets and liabilities, net of the effect of the acquisitions:
increase resulting from changes in operating assets and liabilities, net of the effect of acquisitions:
impairment of right of use assets																0	3,000,000	7,000,000
increase resulting from changes in operating assets and liabilities, net of the effect of the acquisition:
cash paid for acquisition																				0
(distributions to) contributions from non-controlling interest																		-1,000,000
loss on divestiture																			0	0
loss on extinguishment of debt																											0
provisions for inventory and deferred contract costs
proceeds from divestiture																			13,000,000	3,000,000
equity issuance costs
increase in accrued plant, property, and equipment
fair value of equity consideration paid for acquisition
contributions from (distributions to) non-controlling interest																						2,000,000
cash paid for acquisition, net of cash acquired																																			0	0
disbursements for obligations assumed from scitor acquisition																														-2,000,000				-2,000,000	-2,000,000	-1,000,000
decrease in accrued plan share repurchases
benefit from inventory
excess tax benefits from stock-based compensation																																		-4,000,000	-1,000,000	-1,000,000	-5,000,000	-3,000,000	-1,000,000	0	-1,000,000	-1,000,000
loss on disposal of property, plant, and equipment
contributions from non-controlling interest
first quarter																														13,000,000
second quarter																														13,000,000
third quarter																														13,000,000
fourth quarter																														13,000,000
fiscal year																														52,000,000
deferred financing costs																																			0	0	-16,000,000	-1,000,000
increase resulting from changes in operating assets and liabilities net of the effect of the acquisition:
asset acquisition
increase in accrued cash dividend equivalents
science applications international corporationnotes to consolidated financial statements
total cash flows from operating activities																																		35,000,000	108,000,000	68,000,000	21,000,000	29,000,000	96,000,000	82,000,000	65,000,000	34,000,000
change in restricted cash																																		1,000,000	2,000,000	1,000,000
total cash flows used in investing activities																																		-3,000,000	-7,000,000	-4,000,000	-786,000,000	-1,000,000	-7,000,000	-5,000,000	-3,000,000	-7,000,000
total cash flows from financing activities																																			-90,000,000	-43,000,000			-42,000,000			-44,000,000
total increase in cash and cash equivalents
cash and cash equivalents at beginning of period																																		195,000,000	0	0	0	301,000,000	0	0	0	254,000,000
cash and cash equivalents at end of period																																		154,000,000	11,000,000	21,000,000	-132,000,000	295,000,000	47,000,000	7,000,000	10,000,000	237,000,000
total decrease in cash and cash equivalents																																		-41,000,000		21,000,000	-132,000,000	-6,000,000				-17,000,000
decrease in accrued plant, property, and equipment
total cash flows used in financing activities																																		-73,000,000				-34,000,000
basic weighted-average number of shares outstanding																																		45,000,000		0	200,000	45,800,000		-1,000,000
dilutive common share equivalents - stock options and other stock-based awards																																		1,500,000		-200,000	-200,000	1,800,000
diluted weighted-average number of shares outstanding																																		46,500,000		-200,000	0	47,600,000		-700,000
loss on disposal of property, plant and equipment
expenditures for property, plant and equipment																																			-9,000,000	-5,000,000	-5,000,000	-1,000,000	-7,000,000	-5,000,000	-3,000,000	-7,000,000
dividend paid to former parent
net transfers to former parent
capital contribution from former parent
net transfers of property, plant, and equipment from former parent
increase in accrued stock repurchases
favorable adjustments
unfavorable adjustments
net favorable (unfavorable) adjustments
income tax effect
net favorable (unfavorable) adjustments, after tax
basic eps impact
diluted eps impact
increase resulting from changes in operating assets and liabilities
net of the effect of the acquisition:
increase in cash resulting from changes in:
proceeds from sale of assets
proceeds from borrowings under term loan facility
net transfers of property, plant, and equipment from (to) former parent
landlord provided tenant improvements
net transfers of property, plant and equipment from former parent
dilutive common share equivalents—stock options and other stock-based awards
stock repurchased and retired or withheld for taxes on vested restricted stock																																										-33,000,000
net transfers from former parent
adjustments to reconcile net income to net cash from operations:
stock-based compensation
net gain on sales and disposals of assets
borrowing under term loan facility
payment of debt issuance costs
contribution from former parent
dividend payments to common stockholders
issuances of common stock
repurchases of common stock
payments on capital leases and notes payable
supplementary cash flow disclosure

We provide you with 20 years of cash flow statements for Science Applications International stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Science Applications International stock. Explore the full financial landscape of Science Applications International stock with our expertly curated income statements.

The information provided in this report about Science Applications International stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.